Most calciphylaxis patients experience severe hypoalbuminemia, which may contribute to disease progression, as albumin—similar to fetuin-A—acts as an endogenous inhibitor of vascular calcification [24]. The gene discussed is ALB; the disease is Hypoalbuminemia.